Cargando…

Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA

BACKGROUND: The Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA) was established in 2013 with the intention of developing a coordinated mechanism between volunteering EU stakeholders and developers of Orphan Medicinal Products (OMPs) to support the exchange of information aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavaller-Bellaubi, Maria, Hughes-Wilson, Wills, Kubinová, Šárka, Van de Casteele, Marc, Van Lente, Evert Jan, Degortes, Emanuele, Pontén, Johan, Eichler, Hans-Georg, Le Cam, Yann, Boselli, Simone, Bucsics, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258756/ https://www.ncbi.nlm.nih.gov/pubmed/37308991 http://dx.doi.org/10.1186/s13023-023-02774-7

Ejemplares similares

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

A company experience of the first MoCA pilot project
por: Hughes-Wilson, Wills
Publicado: (2014)

Discounts and rebates granted to public payers for medicines in European countries
por: Vogler, Sabine, et al.
Publicado: (2012)

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
por: Hughes-Wilson, Wills, et al.
Publicado: (2012)

Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers
por: Lopata, Erin, et al.
Publicado: (2021)

Overview of alopecia areata for managed care and payer stakeholders in the United States
por: King, Brett, et al.
Publicado: (2023)

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways
por: Ermisch, Michael, et al.
Publicado: (2016)

Using Participatory Learning & Action (PLA) research techniques for inter-stakeholder dialogue in primary healthcare: an analysis of stakeholders’ experiences
por: de Brún, T., et al.
Publicado: (2017)

Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-old
por: Melikyan, Zarui A., et al.
Publicado: (2021)

Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe
por: Medic, Goran, et al.
Publicado: (2017)

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
por: Vella Bonanno, Patricia, et al.
Publicado: (2017)

Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
por: Croft, Nicholas M, et al.
Publicado: (2022)

Multi-Stakeholder Dialogues as Instrument for Design and Qualitative Research in Educational Organisations
por: Helbig, Christian, et al.
Publicado: (2020)

Conversion of MoCA to MMSE scores
por: Falkowski, Jed A., et al.
Publicado: (2015)

Collaborative Governance for Integrated Care: Insights from a Policy Stakeholder Dialogue
por: Gordon, Dara, et al.
Publicado: (2020)

The Clinical Utility of the MOCA in iNPH Assessment
por: Wesner, Eric, et al.
Publicado: (2022)

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
por: Eichler, Hans-Georg, et al.
Publicado: (2023)

Let’s (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues
por: Bauer, Anja, et al.
Publicado: (2020)

Moça com flor na boca : cr{circ}onicas escolhidas
por: Monte, Airton, 1949-
Publicado: (2004)

Combining rules and dialogue: exploring stakeholder perspectives on preventing sexual boundary violations in mental health and disability care organizations
por: Kröger, Charlotte, et al.
Publicado: (2022)

CORRELATION BETWEEN MOCA AND MMSE FOR THE ASSESSMENT OF COGNITION IN SCHIZOPHRENIA
por: Fisekovic, Saida, et al.
Publicado: (2012)

An online monitor of the oxidative capacity of aerosols (o-MOCA)
por: Eiguren-Fernandez, Arantzazu, et al.
Publicado: (2017)

Hospitals and the Tax-Payer
Publicado: (1920)

Stakeholder dialogue on dilemmas at work as a workplace health promotion intervention including employees with a low SEP: a Responsive Evaluation
por: van Heijster, Hanneke, et al.
Publicado: (2022)

Extracellular matrix based biomaterials for central nervous system tissue repair: the benefits and drawbacks
por: Kubinova, Sarka
Publicado: (2017)

Clarifying responsibility: professional digital health in the doctor-patient relationship, recommendations for physicians based on a multi-stakeholder dialogue in the Netherlands
por: Silven, Anna V., et al.
Publicado: (2022)

Comparison of DBFS with MoCA and MMSE tools for MCI screening
por: Chad Chew, Eun Yip, et al.
Publicado: (2023)

The European challenges of funding orphan medicinal products
por: Szegedi, Márta, et al.
Publicado: (2018)

Dialogues in limbo, with three new dialogues
por: Santayana, George, 1863-1952
Publicado: (1957)

Regression-Based Normative Data for the Montreal Cognitive Assessment (MoCA) and Its Memory Index Score (MoCA-MIS) for Individuals Aged 18–91
por: Kessels, Roy P. C., et al.
Publicado: (2022)

Overview of a multi-stakeholder dialogue around Shared Services for Health: the Digital Health Opportunity in Bangladesh
por: Ashraf, Sania, et al.
Publicado: (2015)

Inclusion strategies in multi-stakeholder dialogues: The case of a community-based participatory research on immunization in Nigeria
por: Akwataghibe, Ngozi N., et al.
Publicado: (2022)

Responsive evaluation of stakeholder dialogue as a worksite health promotion intervention to contribute to the reduction of SEP related health inequalities: a study protocol
por: van Heijster, Hanneke, et al.
Publicado: (2020)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Does a public single payer system deliver integrated services? A national survey study among professional stakeholders in Denmark
por: Strandberg-Larsen, Martin, et al.
Publicado: (2008)

Does a public single payer system deliver integrated care? A national survey study among professional stakeholders in Denmark
por: Strandberg-Larsen, Martin, et al.
Publicado: (2008)

Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2021)

Microbe observation and cultivation array (MOCA) for cultivating and analyzing environmental microbiota
por: Gao, Weimin, et al.
Publicado: (2013)

MOCA for Integrated Analysis of Gene Expression and Genetic Variation in Single Cells
por: Huzar, Jared, et al.
Publicado: (2022)

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()()
por: Xu, Yaqian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knsse8cmlamosbks0e3745lp6n